Zaider Marco, Hanin Leonid
Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.
Phys Med Biol. 2007 Oct 21;52(20):6355-62. doi: 10.1088/0031-9155/52/20/017. Epub 2007 Oct 2.
Within the linear-quadratic model the biologically-effective dose (BED)-taken to represent treatments with an equal tumor control probability (TCP)-is commonly (and plausibly) calculated according to BED(D) = -log[S(D)]/alpha. We ask whether in the presence of cellular proliferation this claim is justified and examine, as a related question, the extent to which BED approximates an isoeffective dose (IED) defined, more sensibly, in terms of an equal long-term survival probability, rather than TCP. We derive, under the assumption that cellular birth and death rates are time homogeneous, exact equations for the isoeffective dose, IED. As well, we give a rigorous definition of effective long-term survival time, T(eff). By using several sets of radiobiological parameters, we illustrate potential differences between BED and IED on the one hand and, on the other, between T(eff) calculated as suggested here or by an earlier recipe. In summary: (a) the equations currently in use for calculating the effective treatment time may underestimate the isoeffective dose and should be avoided. The same is the case for the tumor control probability (TCP), only more so; (b) for permanent implants BED may be a poor substitute for IED; (c) for a fractionated treatment schedule, interpreting the observed probability of cure in terms of a TCP formalism that refers to the end of the treatment (rather than T(eff)) may result in a miscalculation (underestimation) of the initial number of clonogens.
在线性二次模型中,通常(且合理地)根据生物学有效剂量(BED)=-log[S(D)]/α来计算具有相等肿瘤控制概率(TCP)的治疗剂量。我们探讨在细胞增殖存在的情况下这一说法是否合理,并作为一个相关问题研究BED在多大程度上近似于更合理地根据相等长期生存概率而非TCP定义的等效应剂量(IED)。在细胞出生和死亡率在时间上均匀的假设下,我们推导出了等效应剂量IED的精确方程。此外,我们给出了有效长期生存时间T(eff)的严格定义。通过使用几组放射生物学参数,我们一方面说明了BED和IED之间的潜在差异,另一方面说明了按照此处建议或早期方法计算的T(eff)之间的差异。总之:(a)目前用于计算有效治疗时间的方程可能会低估等效应剂量,应避免使用。肿瘤控制概率(TCP)也是如此,只是程度更甚;(b)对于永久性植入,BED可能不是IED的良好替代;(c)对于分次治疗方案,根据指治疗结束(而非T(eff))的TCP形式来解释观察到的治愈概率可能会导致对初始克隆原数量的误算(低估)。